Table of Contents

company-logo

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

MaaT Pharma Dividend Announcement

• MaaT Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on MaaT Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

MaaT Pharma Dividend History

MaaT Pharma Dividend Yield

MaaT Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing MaaT Pharma stock? Use our calculator to estimate your expected dividend yield:

MaaT Pharma Financial Ratios

P/E ratio-4.06
PEG ratio-0.05
P/B ratio3.83
ROE-104.77%
Payout ratio0.00%
Current ratio2.76
Quick ratio2.75
Cash Ratio2.12

MaaT Pharma Dividend FAQ

Does MaaT Pharma stock pay dividends?
MaaT Pharma does not currently pay dividends to its shareholders.
Has MaaT Pharma ever paid a dividend?
No, MaaT Pharma has no a history of paying dividends to its shareholders. MaaT Pharma is not known for its dividend payments.
Why doesn't MaaT Pharma pay dividends?
There are several potential reasons why MaaT Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will MaaT Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While MaaT Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is MaaT Pharma a dividend aristocrat?
MaaT Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is MaaT Pharma a dividend king?
MaaT Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is MaaT Pharma a dividend stock?
No, MaaT Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy MaaT Pharma stocks?
To buy MaaT Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy MaaT Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.